MYO9A-CELF6 Fusion FISH Probe
The MYO9A-CELF6 Fusion FISH Probe is used to confirm a fusion of the MYO9A and CELF6 genes. The fusion of the MYO9A and CELF6 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MYO9A-CELF6-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MYO9A-CELF6-20-AQAQ | 20 (40 μL) | 200 μL |
|
MYO9A Gene Summary
This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-9 (MYH9). Unconventional myosins contain the basic domains of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with Bardet-Biedl Syndrome. [provided by RefSeq, Dec 2011]
Gene Name: Myosin IXA
Chromosome: CHR15: 72118360 -72410422
Locus: 15q23
CELF6 Gene Summary
Members of the CELF/BRUNOL protein family contain two N-terminal RNA recognition motif (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 aa between the second and third RRM domains. Members of this protein family regulate pre-mRNA alternative splicing and may also be involved in mRNA editing, and translation. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Feb 2010]
Gene Name: CUGBP Elav-like Family Member 6
Chromosome: CHR15: 72577067 -72612525
Locus: 15q23
Gene Diseases
The MYO9A CELF6 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|